✦ LIBER ✦

Clinical use of novel biomarkers in heart failure: towards personalized medicine

✍ Scribed by Schmitter, Daniela; Cotter, Gadi; Voors, Adriaan A.

Book ID: 120399623
Publisher: Springer
Year: 2013
Tongue: English
Weight: 404 KB
Volume: 19
Category: Article
ISSN: 1382-4147
DOI: 10.1007/s10741-013-9396-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Novel Approach to Drug Development in

A Novel Approach to Drug Development in Heart Failure: Towards Personalized Medicine

✍ Liu, Licette C.Y.; Voors, Adriaan A.; Valente, Mattia A.E.; van der Meer, Peter 📂 Article 📅 2014 🏛 Pulsus Group Inc 🌐 English ⚖ 522 KB

Use of novel biomarkers in heart failure

Use of novel biomarkers in heart failure: How and why?

✍ Koza, Yavuzer 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Use of Multiple Biomarkers in Heart Fail

Use of Multiple Biomarkers in Heart Failure

✍ Larry A. Allen 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 143 KB

The Appropriate Use of Biomarkers in Hea

The Appropriate Use of Biomarkers in Heart Failure

✍ Chowdhury, Punam; Choudhary, Rajiv; Maisel, Alan 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 290 KB

State of Play of Pharmacogenetics and Pe

State of Play of Pharmacogenetics and Personalized Medicine in Heart Failure

✍ Parry, Helen M.; Doney, Alex S.F.; Palmer, Colin N.A.; Lang, Chim C. 📂 Article 📅 2013 🏛 Hindawi Limited 🌐 English ⚖ 216 KB

Essentials of Genomic and Personalized M

Essentials of Genomic and Personalized Medicine || Heart Failure in the Era of Genomic Medicine

✍ Benjamin, Ivor J. 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 307 KB

Derived from the comprehensive two-volume set, *Genomic and Personalized Medicine* also edited by Drs. Willard and Ginsburg, this work serves the needs of the evolving population of scientists, researchers, practitioners and students that are embracing one of the most promising avenues for advances